Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Randomized trial of preoperative chemoradiation versus surgery alone in patients with... A pilot study of 43 patients with potentially resectable esophageal carcinoma treated with an intensive regimen of preoperative chemoradiation with cisplatin, fluorouracil, and vinblastine before surgery showed a median survival of 29 months in comparison with the 12-month median survival of 100 historical controls treated with surgery alone at the same institution. We designed a randomized trial to compare survival for patients treated with this preoperative chemoradiation regimen versus surgery alone. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of clinical oncology : official journal of the American Society of Clinical Oncology Pubmed

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology , Volume 19 (2): 9 – Mar 29, 2001

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.


Abstract

A pilot study of 43 patients with potentially resectable esophageal carcinoma treated with an intensive regimen of preoperative chemoradiation with cisplatin, fluorouracil, and vinblastine before surgery showed a median survival of 29 months in comparison with the 12-month median survival of 100 historical controls treated with surgery alone at the same institution. We designed a randomized trial to compare survival for patients treated with this preoperative chemoradiation regimen versus surgery alone.

Loading next page...
 
/lp/pubmed/randomized-trial-of-preoperative-chemoradiation-versus-surgery-alone-uWOT0RsbZK

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0732-183X
DOI
10.1200/JCO.2001.19.2.305
pmid
11208820

Abstract

A pilot study of 43 patients with potentially resectable esophageal carcinoma treated with an intensive regimen of preoperative chemoradiation with cisplatin, fluorouracil, and vinblastine before surgery showed a median survival of 29 months in comparison with the 12-month median survival of 100 historical controls treated with surgery alone at the same institution. We designed a randomized trial to compare survival for patients treated with this preoperative chemoradiation regimen versus surgery alone.

Journal

Journal of clinical oncology : official journal of the American Society of Clinical OncologyPubmed

Published: Mar 29, 2001

There are no references for this article.